The cost of hepatitis A infections in American adolescents and adults in 1997

Hepatology

Volumn 31, Issue 2, 2000, Pages 469-473

  Berge, Jeremy J ^a   Drennan, David P ^a   Jacobs, R Jake ^b   Jakins, Alan ^c   Meyerhoff, Allen S ^b   Stubblefield, Wayne ^d   Weinberg, Melvyn ^e  

^a Private Practice   (United States)

^b Capitol Outcomes Research Inc   (United States)

^c Private Practice   (United States)

^d Private Practice   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HEALTH CARE COST; HEPATITIS A; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEROLOGY; VACCINATION;

EID: 0033974310     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310229     Document Type: Article

References (11)

1. Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral Hepatitis and Liver Disease. Baltimore, MD: Williams & Wilkins, 1991;14-19.
2. Hepatitis Surveillance Report Number 56. Atlanta, GA: Centers for Disease Control and Prevention, 1996.
3. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992;10(Suppl 1):59S-62S.
4. Tormans G, Van Damme P, Van Doorslaer E. Cost effectiveness analysis of hepatitis A prevention in travellers. Vaccine 1992;10(Suppl 1):88S-92S.
5. Van Doorslaer E, Tormans G, Van Damme P. Cost effectiveness analysis of vaccination against hepatitis A in travellers. J Med Virol 1994;44:463-469.
6. Shapiro C, Arcani C, Mast E, Bell B, Coleman P, Haddix A, Margolis H. An economic analysis of the uses of hepatitis A vaccine to control community wide epidemics. Presented at the IX Triennial International Symposium on Viral Hepatitis and Liver Disease. Rome, Italy, April 21-25, 1996.
7. Smith S, Weber S, Wiblin T, Nettleman M. Cost-effectiveness of hepatitis A vaccination in healthcare workers. Infect Control Hosp Epidemiol 1997;18:688-691.
8. Das, A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. HEPATOLOGY 1999;29:548-552.
9. Jacobs RJ, Meyerhoff AS. Vaccination of sexually active homosexual men against hepatitis A: analysis of costs and benefits. Journal of the Gay and Lesbian Medical Association 1999;3:51-58.
10. Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987;125:133-139.
11. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995;311:376-380.